Opko Health OPK
NASDAQ OPK
$1.73 +0.03 (+2.07%)
As of: Sep 22, 2026 · 11:37 AM EDT

Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024)

Opko Health's (OPK) quarterly Non-Current Deffered Revenue came in at $7000.0 in Q3 2024, down 94.85% on a YoY basis from $136000.0 in Q4 2023, and little changed quarter-over-quarter from $7000.0 in Q2 2024.

Analysis

Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends

Opko Health (OPK) has reported Non-Current Deffered Revenue for 3 consecutive years, with $7000.0 the latest figure, recorded in Q3 2024.

  • For the quarter ending Q3 2024, Non-Current Deffered Revenue fell 94.85% year-over-year to $7000.0; the trailing twelve-month figure through Sep 2024 stood at $7000.0 (down 94.85% YoY), and the FY2024 full-year result was $7000.0, changed N/A from the prior year.
  • Non-Current Deffered Revenue was little changed at $7000.0 in Q3 2024 per OPK's latest filing, from $7000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $140000.0 in Q2 2023 and bottomed at $7000.0 in Q4 2023.
  • Historically, Non-Current Deffered Revenue has averaged $63142.9 across 3 years, with a median of $7000.0 in 2023.
  • The widest YoY moves for Non-Current Deffered Revenue: up 94.85% in 2024, down 95.0% in 2024.
  • Over 3 years, Non-Current Deffered Revenue stood at $138000.0 in 2022, then plunged by 94.93% to $7000.0 in 2023, then changed by 0.0% to $7000.0 in 2024.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $7000.0, $7000.0, and $7000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 7,000.00
Jun 30, 2024 7,000.00
Mar 31, 2024 7,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 136,000.00
Jun 30, 2023 140,000.00
Dec 31, 2022 138,000.00
API Access

Opko Health Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=OPK&period=max&api_key=YOUR_API_KEY